10-HYDROXYCAMPTOTHECIN: 33 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
33
Total FAERS Reports
5 (15.2%)
Deaths Reported
1
Hospitalizations
33
As Primary/Secondary Suspect
First Report: 20200101 · Latest Report: 20200101
What Are the Most Common 10-HYDROXYCAMPTOTHECIN Side Effects?
#1 Most Reported
Post embolisation syndrome
20 reports (60.6%)
#2 Most Reported
Off label use
20 reports (60.6%)
#3 Most Reported
Device use issue
20 reports (60.6%)
All 10-HYDROXYCAMPTOTHECIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Device use issue | 20 | 60.6% | 4 | 0 |
| Off label use | 20 | 60.6% | 4 | 0 |
| Post embolisation syndrome | 20 | 60.6% | 4 | 0 |
Who Reports 10-HYDROXYCAMPTOTHECIN Side Effects? Age & Gender Data
Gender: 33.3% female, 66.7% male. Average age: 56.1 years. Most reports from: CN. View detailed demographics →
Is 10-HYDROXYCAMPTOTHECIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2020 | 1 | 0 | 0 |
What Is 10-HYDROXYCAMPTOTHECIN Used For?
| Indication | Reports |
|---|---|
| Therapeutic embolisation | 19 |
| Hepatocellular carcinoma | 12 |
Official FDA Label for 10-HYDROXYCAMPTOTHECIN
Official prescribing information from the FDA-approved drug label.